Continued uncertainty on the legality of ‘top-ups’ has caused untold anxiety for breast cancer patients, so today’s announcement that those paying for drugs will not lose access to NHS care will bring relief to many. |  |
Thousands of people with advanced breast cancer are suffering appalling gaps in essential support and care which is routinely offered to patients with primary breast cancer. | |
The majority of breast cancer patients in England are routinely failing to receive essential psychological and emotional support despite government calls for, and NICE guidance on, the provision of such care, it is revealed today. | |
Comment on research published in the New England Journal of Science, from Cancer Research UK which claims that a single mammogram reader using Computer Aided Detection (CAD) can be as effective as the two readers traditionally used in the UK. | |
Commenting on research presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston on the use of acupuncture in reducing vasomotor symptoms associated with breast cancer treatment. | |
Commenting on the UK launch of Tyverb as a treatment for secondary (metastatic) breast cancer, Antonia Dean, Clinical Nurse Specialist at Breast Cancer Care, said: | |
Latest research from Breast Cancer Care1 shows that the majority of breast cancer patients are not aware of their employment rights once diagnosed. | |
Comment on research presented to the American Society of Clinical Oncology (ASCO) 2008 meeting, which claims that combining pertuzumab with Herceptin shows significant tumour response in women with advanced HER2-positive breast cancer.
| |
Comment on data presented at the American Society for Clinical Oncology’s Annual Meeting which shows that continued treatment with Herceptin helps women with late stage HER2-positive breast cancer live longer with their cancer under control.
| |
Comment on a report from the Office of National Statistics which shows that while breast cancer incidence is increasing, mortality rates are declining. | |
Comment on research from the National Cancer Institute, Maryland, which suggests that the use of daily non-steroidal anti-inflammatory drugs, such as Aspirin, can reduce the risk of developing oestrogen positive breast cancer. | |
The UK’s first-ever book to help young children whose mums have been diagnosed with breast cancer has been launched by Breast Cancer Care. | |
Comment on research by Dr IngaLill Koinberg at Kristianstad University, Sweden, on the cost of follow-up care for breast cancer patients, presented at the European Breast Cancer Conference.
| |
Comment on the UK Breast Screening Frequency trial led by Nottingham City Hospital, UK, presented at the European Breast Cancer Conference in Berlin.
| |
Comment on research from the Vestfold Central Hospital, Norway, on the use of acupuncture for the relief of hot flushes in patients taking tamoxifen. | |
Comment on research from the Erasmus Medical Centre, Rotterdam on the benefits of breast screening for women aged up to 75, presented at the European Breast Cancer Conference.
| |
Comment on research from the Lester and Sue Smith Breast Centre, Houston, USA, on the use of lapatinib for the treatment of primary breast cancer, presented at the European Breast Cancer Conference. | |
Statement in response to research from Jules Bordet Institute, Brussels, presented to the European Breast Cancer Conference which claims that obese women with breast cancer have negative treatment outcomes. | |
Comment on research from the German Breast Group on the level of treatment given to pregnant breast cancer patients, presented at the European Breast Cancer Conference. | |
Comment on research from the Health and Environment Alliance and the CHEM Trust which claims that continued exposure to hormone disrupting chemicals can cause breast cancer.
| |